Zürich (ots) - Im September 2017 bleiben die Angebotsmieten in der Schweiz unverändert. Der Index ...
155,000 New Customers now Available to MedifyRemote(TM)
Toronto, Canada (ots/PRNewswire) - Due to the significance of the Vodafone Medify Solutions Limited release issued yesterday (11/01/2007), please find below important notes for interested parties. Vodafone UK will be issuing further news directly through their wire and related online media and PR department on this development.
MedifyRemote(TM) is now a Vodafone Certified application.
@@start.t1@@ Who are Vodafone?
Vodafone Group Plc is the world's leading mobile telecommunications
company, with a significant presence in Europe, the Middle East,
Africa, Asia Pacific and the United States.
The Group's mobile subsidiaries operate under the brand name
'Vodafone'. In the United States the Group's associated undertaking
operates as Verizon Wireless.
At 30 September 2006, the Group had 191.6 million customers.
The Company had a total market capitalisation of approximately
GBP 80 billion at 15 November 2005.
Why is the Certified Status of MedifyRemote(TM) significant?
Vodafone UK is the largest network operator in the UK.
Vodafone UK has the largest market share of NHS customers with
155,000 existing users, delivering the maximum single immediate route
to market for MedifyRemote(TM).
Vodafone UK has a dedicated NHS specialist sales team who are now
actively retailing MedifyRemote(TM).
Vodafone will supply product support through its extensive customer
service support teams.
What is MedifyRemote(TM)?
MedifyRemote(TM) is the first secure mobile patient note access
application to enter field use throughout the NHS.
MedifyRemote(TM) allows the healthcare professional to access, review
and update the patients' complete medical history in a single, secure
session via a Microsoft Windows enabled PDA device.@@end@@
As of 11/01/07 MedifyRemote(TM) is available to order through Medify
Solutions Limited, Vodafone UK or EMIS.
Further news will be issued directly by Vodafone UK
This news release contains forward-looking statements that are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected on the basis of such forward-looking statements. The words "estimate," "project," "intends," "expects," " believes," and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbour" provisions of the Private Securities Litigation Reform Act of 1995. For a more complete description of these and other risk factors that may affect the future performance of Medify Solutions Limited, see "Risk Factors" in the Company's Annual Report on Form 10-KSB and its other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made and the Company undertakes no obligation to disclose any revision to these forward-looking statements to reflect events or circumstances after the date made or to reflect the occurrence of unanticipated events.
(Pink Sheets - MDFY)
For Vodafone please visit www.vodafone.co.uk/business/
ots Originaltext: Medify Solutions Ltd.
Im Internet recherchierbar: http://www.presseportal.ch